STOCK TITAN

LifeVantage to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

(Neutral)
(Neutral)
Tags
conferences

LifeVantage (Nasdaq: LFVN), a health and wellness company focused on cellular health products, has announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference. The event will take place from September 8-10, 2025, in New York, NY.

President and CEO Steve Fife, along with CFO Carl Aure, will conduct investor meetings and deliver a presentation on Wednesday, September 10, 2025, at 1:00 p.m. Eastern Time. The presentation will be available via live webcast on the company's investor relations website, with a replay accessible for approximately 90 days afterward.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – LFVN

+0.15%
1 alert
+0.15% Session close to close
$170.82M Market Cap
0.8x Rel. Volume

In the Sep 3 session, LFVN gained 0.15%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the H.C. Wainwright 27th Annual Global Investment Conference, to be held September 8-10, 2025 in New York, NY.

Mr. Fife and Mr. Aure will meet with investors and present at approximately 1:00 p.m. Eastern Time on Wednesday, September 10, 2025. A live webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at https://lifevantage.gcs-web.com/ or directly here. A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company’s website.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Investor Relations Contact:

Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com


FAQ

When is LifeVantage (LFVN) presenting at the H.C. Wainwright Conference 2025?

LifeVantage will present on Wednesday, September 10, 2025, at 1:00 p.m. Eastern Time.

Who will represent LifeVantage (LFVN) at the H.C. Wainwright Conference?

Steve Fife, President and CEO, and Carl Aure, CFO, will represent LifeVantage at the conference.

How can investors access LifeVantage's (LFVN) H.C. Wainwright Conference presentation?

Investors can access the live webcast through LifeVantage's Investor Relations website at https://lifevantage.gcs-web.com/. A replay will be available for approximately 90 days.

What is the duration of the H.C. Wainwright Conference 2025?

The H.C. Wainwright Global Investment Conference will be held from September 8-10, 2025 in New York, NY.